# Ketamine for Endoscopic Sedation in Outpatient Adult Endoscopy.

> **NCT03461718** · PHASE2 · COMPLETED · sponsor: **Brooke Army Medical Center** · enrollment: 66 (actual)

## Conditions studied

- Administration and Dosage of Ketamine
- Endoscopic Sedation

## Interventions

- **DRUG:** Ketamine
- **DRUG:** Midazolam injection
- **DRUG:** Fentanyl

## Key facts

- **NCT ID:** NCT03461718
- **Lead sponsor:** Brooke Army Medical Center
- **Sponsor class:** FED
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-03-05
- **Primary completion:** 2019-10-01
- **Final completion:** 2019-10-01
- **Target enrollment:** 66 (ACTUAL)
- **Last updated:** 2020-07-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03461718

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03461718, "Ketamine for Endoscopic Sedation in Outpatient Adult Endoscopy.". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT03461718. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*